Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06199154 · ClinicalTrials.gov registry record · Early Phase 1
Induction of Labor in Morbidly Obese Patients
A Early Phase 1 study of Pregnancy and Morbid Obesity, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT06199154: Recruiting Early Phase 1 study of Pregnancy and Morbid Obesity, sponsored by University of Maryland, Baltimore.
NCT06199154 is a Early Phase 1 study of Pregnancy and Morbid Obesity that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 162 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06199154, a Early Phase 1 study of Pregnancy and Morbid Obesity, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI \>40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vaginal delivery in this population can improve, then surgical morbidity can be reduced in these patients.
Conditions Studied
Interventions
- DRUG Misoprostol
Study Locations (1)
Maryland
- University of Maryland Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2026-10 |
| Phase | Early Phase 1 |
What NCT06199154 shows while recruiting
NCT06199154 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Misoprostol is the first listed.
NCT06199154 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06199154 about?
NCT06199154 is a clinical study titled "Induction of Labor in Morbidly Obese Patients". The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI \>40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vagin...
What is the current status of trial NCT06199154?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 162 participants. The study started on 2024-07-15. Estimated completion is 2026-10.
What conditions does trial NCT06199154 study?
This clinical trial studies the following conditions: Pregnancy, Morbid Obesity.
What interventions are being tested in trial NCT06199154?
The interventions under investigation include: Misoprostol (DRUG).
Who is sponsoring clinical trial NCT06199154?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06199154 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06199154's enrollment target sits among peer trials
162 93rd of 191 higher than 99 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Inpatient Adolescent Contraception
COMPLETED · Early Phase 1
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI